GlassScriptPhysician profile
Ryan P Fritsch
NPI 1184824658
$2,871.77
in general payments reported to CMS, 2019-2025
13 companies · $797 in 2025
The $797 reported for 2025 was more than what 87% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $130 · 2021: $248 · 2022: $372 · 2023: $256 · 2024: $720 · 2025: $797.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,773.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,772.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $722.03 | 2021-2025 | Precision7, Precision 1, Total30 |
| Bausch & Lomb Americas INC. | $377.49 | 2022-2025 | Infuse, Infuse Multifocal, Biotrue One Day |
| Coopervision INC. | $376.13 | 2019-2025 | Myday Contact Lens, Misight Contact Lens |
| Johnson & Johnson Vision Care, INC. | $309.67 | 2019-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $281.98 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $276.25 | 2024-2025 | Xdemvy |
| Oyster Point Pharma, INC. | $179.24 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Dompe US, INC. | $123.26 | 2024 | Oxervate |
| Allergan, INC. | $121.73 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $71.89 | 2019-2022 | |
| Biotissue Holdings INC. | $19.74 | 2025 | |
| Aerie Pharmaceuticals, INC. | $12.36 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Fritsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.